FABRX

@FabRx_3DP

FABRX is biotech company focused on pharmaceutical 3D printing technology for manufacturing personalised human and veterinary medicines and medical devices.

London, England fabrx.co.uk Joined March 2016

201 Following 622 Followers 605 Posts

Latest posts 5

FABRX @FabRx_3DP Feb 23

A new regulatory framework treats printable ink as a pharmaceutical intermediate. This risk-based approach makes semi-solid extrusion 3D printing feasible in hospitals, enabling patient-specific medicines at the point of care.

🔗 Read the full paper: lnkd.in/eCAxNVJ6

One of the most impactful concepts proposed by the authors is treating the printable ink as a pharmaceutical intermediate, creating a practical bridge between hospital compounding and GMP environments.
This risk-based approach enables the implementation of semi-solid extrusion (SSE) 3D printing in real clinical settings, offering a realistic pathway toward patient-specific medicines produced directly at the point of care.

FABRX @FabRx_3DP Feb 20

The Syringe Preheater was designed to remove the most common hidden bottlenecks in automated production: inconsistent material conditions between syringes.

By keeping all syringes at controlled, homogeneous conditions, always ready to go. Do not let the printer have a break!

0:34

FABRX @FabRx_3DP Feb 19

New from the pharmacy department at @GustaveRoussy : a practical, risk-based framework for semi-solid extrusion 3D printing that connects hospital compounding with early-phase clinical trials under a unified regulatory vision.

🔗 Read the full paper: sciencedirect.com/science/articl…

Open-access publication bringing hospital-based pharmaceutical 3D printing one step closer to routine clinical practice.
Led by the pharmacy department at Gustave Roussy, this study proposes a practical, risk-based framework for semi-solid extrusion (SSE) 3D printing that bridges hospital compounding and early-phase clinical trials within a unified regulatory vision.
Using real paediatric use cases with multiple APIs, the authors demonstrate how hospitals can implement personalised 3D-printed medicines with traceability, reproducibility, and regulatory alignment.

FABRX @FabRx_3DP Feb 18

We’re just one month away from @EAHPofficial Congress 2026!

📍 Visit Booth 13 at CCIB, Barcelona | 18–20 March
See 3D printing in action and discover how it can support hospital compounding.

⏳ We’re just one month away from EAHP Congress 2026!
We will be showcasing how the M3DIMAKER enables hospital pharmacies to produce personalised medicines at the point of care.
Why hospital pharmacies choose FABRX:
⚡ 9× faster than manual compounding
👷‍♂️ 55 % reduction in manual labour
💰 40 % operational cost savings
🛡️ Improved safety and efficiency

FABRX @FabRx_3DP Feb 13

Thanks to 3D printing, hospital pharmacies can now prepare chewable units tailored to each child.
Each dose represents more than a treatment, it is a step towards making therapy easier and more manageable for young patients.

📖 Read the full article here: sciencedirect.com/science/articl…